Sol-Gel Technologies Announces Leadership Changes
Company Announcements

Sol-Gel Technologies Announces Leadership Changes

Sol-Gel Technologies (SLGL) has released an update.

Sol-Gel Technologies Ltd., an innovative dermatology company, announced a management realignment with CEO Dr. Alon Seri-Levy stepping down by the end of 2024 and Eyal Ben-Or being appointed as the new CFO. Under Dr. Seri-Levy’s tenure, the company launched FDA-approved products EPSOLAY® and TWYNEO® and completed a successful U.S. IPO. The company is also conducting a Phase 3 clinical trial for SGT-610, a treatment for Gorlin syndrome.

For further insights into SLGL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskSol-Gel Technologies Appoints Interim CEO and Approves New Incentive Plan
TipRanks Auto-Generated NewsdeskSol-Gel Technologies Announces Upcoming Special Meeting
TipRanks Auto-Generated NewsdeskSol-Gel Technologies Announces Key Shareholder Decisions
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App